Indigenous Kovid-19 drug 2-DG introduced in India

According to local media reports, in cooperation with the Institute of Nuclear Medicine and Related Sciences (INMAS) of the Defense Research and Development Authority (DRDO) of the Ministry of Defense of India and the Dr Reddy Laboratory, 2-deoxy-D-glucose (2-DG) against Kovid-19 ) drug was developed.

Indian Defense Minister Rajnath Singh handed over 2DG to Indian Health Minister Harsh Vardhan at the presentation of the first batch of the drug, which was approved for emergency use as a result of the examination and evaluations.

In his speech at the presentation, Vardhan stated that with the support of DRDO and the leadership of Defense Minister Singh, this drug could be the first research-based domestic result in the fight against Kovid-19.

Minister Vardhan said the drug reduces the healing process and dependence on oxygen.

The drug is first expected to be used in hospitals in the capital, New Delhi.

On the other hand, some experts pointed out that there is not enough data for the drug to be used in the treatment of Kovid-19.

Stating that there is not enough data on its effectiveness in human trials, experts said that the drug in question was first developed and tested for cancer treatment.

While 24 million 965 thousand 463 cases were detected in India, 274 thousand 390 people died due to the virus.